Genetic alterations during treatment of oligometastatic colorectal cancer (GATTACA)

Organizational Data

DRKS-ID:
DRKS00006294
Recruitment Status:
Recruiting complete, study continuing
Date of registration in DRKS:
2017-01-12
Last update in DRKS:
2023-02-16
Registration type:
Retrospective

Acronym/abbreviation of the study

GATTACA

URL of the study

No Entry

Brief summary in lay language

Aim of this pilot study is to assess the influence of local tumor irradication on the evolution of genetic alterations of circulating tumor DNA in metastatic colorectal carcinoma undergoing systemic chemotherapy plus targeted therapy.

Brief summary in scientific language

Assesment of the Influences on the evolution of genetic alterations of circulating tumor DNA in patients with metastasized CRC undergoing chemotherapie and local tumor irradication.

Health condition or problem studied

ICD10:
C20 - Malignant neoplasm of rectum
ICD10:
C19 - Malignant neoplasm of rectosigmoid junction
ICD10:
C18 - Malignant neoplasm of colon
Healthy volunteers:
No Entry

Interventions, Observational Groups

Arm 1:
Patients treated in this study receive a local Therapy (Thermal ablation, Brachytherapy, Mikrowaveablation, stereotactical radiation, surgical resection) after there has been a progress while undergoing Chemotherapy. The study will only accompany the intended Treatment, but not influence the chosen methods. During the study additional blood samples will be taken during routine blood draws to examinate whether changes in free floating DNA will occur after local Therapy.

Endpoints

Primary outcome:
There is a proportionality between the fall of the free-circulating tumor DNA 8 weeks after therapy and 16-72 week interval and the progression free survival and / or overall survival. (Check of the degree of response)
Secondary outcome:
Is tumor recurrence (Progression free survival) associated with a different profile of genetic alterations?

Study Design

Purpose:
Prognosis
Retrospective/prospective:
No Entry
Study type:
Non-interventional
Longitudinal/cross-sectional:
No Entry
Study type non-interventional:
No Entry

Recruitment

Recruitment Status:
Recruiting complete, study continuing
Reason if recruiting stopped or withdrawn:
No Entry

Recruitment Locations

Recruitment countries:
  • Germany
Number of study centers:
Multicenter study
Recruitment location(s):
  • University medical center Klinik für Radiologie und Nuklearmedizin Magdeburg
  • University medical center Leipzig
  • University medical center Klinik und Poliklinik für Radiologie München

Recruitment period and number of participants

Planned study start date:
No Entry
Actual study start date:
2016-03-02
Planned study completion date:
No Entry
Actual Study Completion Date:
No Entry
Target Sample Size:
90
Final Sample Size:
87

Inclusion Criteria

Sex:
All
Minimum Age:
18 Years
Maximum Age:
no maximum age
Additional Inclusion Criteria:
1. histologically proven oligometastatic colorectal cancer (Oligometastatic disease status defined as involving up to 3 organ systems; up to 3 metastases per organ system) 2. Any treatment line irrespective of previous chemotherapy lines 3.Patient treatment recommendation confirmed by an institutional multidisciplinary tumor board (MDT) 4.Metastases amenable to complete ablation/resection using different techniques (radiofrequency ablation, thermoablation, photon beam radiation, surgery, including minimal invasive resections) 5.Age >18 Jahre 6.Life expectancy > 12 months 7. signed and dated consent form

Exclusion Criteria

1. Patients with metastases involving more than 3 organ systems (e.g. liver, lung, bone and retroperitoneal compartment) 2. Patients with peritoneal or pleural metastases 3. Patient having undergone Whipple Operation 4. Second carcinoma, except carcinoma in situ of the cervix or basal cell carcinoma. 5. Pregnancy

Addresses

Primary Sponsor

Address:
Klinikum der Universität München, Campus Großhadern
Marchioninistraße 15
81377 München
Germany
Telephone:
No Entry
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
http://www.klinikum.uni-muenchen.de
Investigator Sponsored/Initiated Trial (IST/IIT):
Yes

Contact for Scientific Queries

Address:
Klinik für Radiologie und NuklearmedizinUniversität Magdeburg
Prof. Jens Ricke
Leipziger Str. 44
39120 Magdeburg
Germany
Telephone:
+391-6713030
Fax:
+391-6713029
Contact per E-Mail:
Contact per E-Mail
URL:
http://www.med.uni-magdeburg.de/fme/zrad/kdr/

Contact for Public Queries

Address:
Klinik und Poliklinik für Radiologie Klinikum der Universität München Campus Großhadern
Christel Besseler
Marchioninistr. 15
81377 München
Germany
Telephone:
(089) 4400-73647
Fax:
(089) 4400-76648
Contact per E-Mail:
Contact per E-Mail
URL:
http://intranet.klinikum.uni-muenchen.de/de/index.html

Principal Investigator

Address:
Klinik für Radiologie und NuklearmedizinUniversität Magdeburg
Prof. Jens Ricke
Leipziger Str. 44
39120 Magdeburg
Germany
Telephone:
+391-6713030
Fax:
+391-6713029
Contact per E-Mail:
Contact per E-Mail
URL:
http://www.med.uni-magdeburg.de/fme/zrad/kdr/

Sources of Monetary or Material Support

Institutional budget, no external funding (budget of sponsor/PI)

Address:
Klinikum der Universität München, Campus Großhadern
Marchioninistraße 15
81377 München
Germany
Telephone:
No Entry
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
http://www.klinikum.uni-muenchen.de

Ethics Committee

Address Ethics Committee

Address:
Ethik-Kommission der Otto-von-Guericke-Universität an der Medizinischen Fakultät und am Universitätsklinikum Magdeburg A.ö.R.
Leipziger Str. 44 Haus 28
39120 Magdeburg
Germany
Telephone:
+49-391-6714314
Fax:
+49-391-67290185
Contact per E-Mail:
Contact per E-Mail
URL:
No Entry

Vote of leading Ethics Committee

Vote of leading Ethics Committee
Date of ethics committee application:
2014-06-30
Ethics committee number:
95/14
Vote of the Ethics Committee:
Approved
Date of the vote:
2014-07-07

Further identification numbers

Other primary registry ID:
No Entry
EudraCT Number:
No Entry
Other secondary IDs:
LMU-RAD00001 - Klinik und Poliklinik für Radiologie
UTN (Universal Trial Number):
No Entry
EUDAMED Number:
No Entry

IPD - Individual Participant Data

Do you plan to make participant-related data (IPD) available to other researchers in an anonymized form?:
No
IPD Sharing Plan:
No Entry

Study protocol and other study documents

Study protocols:
No Entry
Study abstract:
No Entry
Other study documents:
No Entry
Background literature:
No Entry
Related DRKS studies:
No Entry

Publication of study results

Planned publication:
No Entry
Publikationen/Studienergebnisse:
No Entry
Date of first publication of study results:
No Entry
DRKS entry published for the first time with results:
No Entry

Basic reporting

Basic Reporting / Results tables:
No Entry
Brief summary of results:
No Entry